The future of heart disease treatment may change after a study found that a common post-heart attack medication might not be ...

A major international study is forcing doctors to take a second look at one of the world’s most common heart treatments.

A major international study suggests beta blockers may not benefit many patients recovering from uncomplicated heart attacks ...

A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit for ...

Emerging details follow a May 12 report affecting more than 17,000 bottles of a commonly prescribed blood pressure drug.

Heart disease is the leading cause of death in the U-S. But even with all the information available, some people wonder which drugs they should take -- and who really needs them. Experts agree that ...

The base editing medicine lowered “bad” cholesterol levels along with a key protein, clearing the way for a Phase 2 study.

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart ...

AS drug shortages have reached a record high in England, there are a handful of medications that are particularly at risk of facing supply issues – from certain beta-blockers to ...

(Reuters) - Bayer will move a heart failure drug into final-stage testing this year, boosting its ambitions in cardiovascular treatments after the experimental medicine showed a "striking" reduction ...

In recent years, the use of male performance-enhancing drugs has become increasingly popular among men of various age groups. These drugs — often marketed as solutions for erectile dysfunction or to ...